vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and PubMatic, Inc. (PUBM). Click either name above to swap in a different company.
PubMatic, Inc. is the larger business by last-quarter revenue ($62.6M vs $62.1M, roughly 1.0× Cytek Biosciences, Inc.). PubMatic, Inc. runs the higher net margin — -20.0% vs -70.9%, a 50.9% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -2.0%). PubMatic, Inc. produced more free cash flow last quarter ($10.7M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -3.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
PubMatic, Inc. develops and implements online advertising software and strategies for the digital publishing and advertising industry. PubMatic's sell-side, real-time programmatic ad transaction advertising software puts publishers of websites, videos, and mobile apps into contact with ad buyers by using automated systems, while allowing users to opt-out of having their personal information collected on internet searches. PubMatic has a number of offices in countries around the world.
CTKB vs PUBM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $62.6M |
| Net Profit | $-44.1M | $-12.5M |
| Gross Margin | 52.9% | 58.3% |
| Operating Margin | -9.0% | 17.3% |
| Net Margin | -70.9% | -20.0% |
| Revenue YoY | 8.1% | -2.0% |
| Net Profit YoY | -557.1% | -31.9% |
| EPS (diluted) | — | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $62.6M | ||
| Q4 25 | $62.1M | $80.0M | ||
| Q3 25 | $52.3M | $68.0M | ||
| Q2 25 | $45.6M | $71.1M | ||
| Q1 25 | $41.5M | $63.8M | ||
| Q4 24 | $57.5M | $85.5M | ||
| Q3 24 | $51.5M | $71.8M | ||
| Q2 24 | $46.6M | $67.3M |
| Q1 26 | — | $-12.5M | ||
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $-6.5M | ||
| Q2 25 | $-5.6M | $-5.2M | ||
| Q1 25 | $-11.4M | $-9.5M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $-912.0K | ||
| Q2 24 | $-10.4M | $2.0M |
| Q1 26 | — | 58.3% | ||
| Q4 25 | 52.9% | 68.2% | ||
| Q3 25 | 52.7% | 62.6% | ||
| Q2 25 | 52.3% | 62.6% | ||
| Q1 25 | 48.6% | 59.9% | ||
| Q4 24 | 58.5% | 70.8% | ||
| Q3 24 | 56.3% | 64.5% | ||
| Q2 24 | 54.6% | 62.6% |
| Q1 26 | — | 17.3% | ||
| Q4 25 | -9.0% | 10.6% | ||
| Q3 25 | -17.6% | -12.4% | ||
| Q2 25 | -23.3% | -7.7% | ||
| Q1 25 | -36.1% | -18.6% | ||
| Q4 24 | 5.2% | 17.3% | ||
| Q3 24 | -8.2% | -1.9% | ||
| Q2 24 | -18.3% | -5.9% |
| Q1 26 | — | -20.0% | ||
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | -9.5% | ||
| Q2 25 | -12.2% | -7.3% | ||
| Q1 25 | -27.5% | -14.9% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | -1.3% | ||
| Q2 24 | -22.4% | 2.9% |
| Q1 26 | — | $-0.27 | ||
| Q4 25 | — | $0.14 | ||
| Q3 25 | — | $-0.14 | ||
| Q2 25 | — | $-0.11 | ||
| Q1 25 | — | $-0.20 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | — | $-0.02 | ||
| Q2 24 | — | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $144.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $251.0M |
| Total Assets | $461.5M | $659.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $144.9M | ||
| Q4 25 | $90.9M | $145.5M | ||
| Q3 25 | $93.3M | $136.5M | ||
| Q2 25 | $75.5M | $90.5M | ||
| Q1 25 | $95.3M | $101.8M | ||
| Q4 24 | $98.7M | $100.5M | ||
| Q3 24 | $162.3M | $78.9M | ||
| Q2 24 | $177.9M | $73.5M |
| Q1 26 | — | $251.0M | ||
| Q4 25 | $341.7M | $262.6M | ||
| Q3 25 | $378.6M | $245.1M | ||
| Q2 25 | $377.6M | $243.3M | ||
| Q1 25 | $379.6M | $275.6M | ||
| Q4 24 | $395.7M | $277.3M | ||
| Q3 24 | $385.5M | $263.2M | ||
| Q2 24 | $389.1M | $282.7M |
| Q1 26 | — | $659.4M | ||
| Q4 25 | $461.5M | $680.2M | ||
| Q3 25 | $494.9M | $676.2M | ||
| Q2 25 | $493.3M | $675.2M | ||
| Q1 25 | $482.6M | $668.6M | ||
| Q4 24 | $499.5M | $739.5M | ||
| Q3 24 | $491.2M | $689.1M | ||
| Q2 24 | $483.7M | $673.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $17.3M |
| Free Cash FlowOCF − Capex | $-1.8M | $10.7M |
| FCF MarginFCF / Revenue | -2.9% | 17.1% |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $63.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $17.3M | ||
| Q4 25 | $-771.0K | $18.2M | ||
| Q3 25 | $-3.9M | $32.4M | ||
| Q2 25 | $108.0K | $14.9M | ||
| Q1 25 | $-125.0K | $15.6M | ||
| Q4 24 | $2.0M | $18.0M | ||
| Q3 24 | $13.2M | $19.1M | ||
| Q2 24 | $6.2M | $11.9M |
| Q1 26 | — | $10.7M | ||
| Q4 25 | $-1.8M | $11.3M | ||
| Q3 25 | $-4.6M | $27.7M | ||
| Q2 25 | $-1.5M | $13.6M | ||
| Q1 25 | $-974.0K | $14.2M | ||
| Q4 24 | $1.1M | $13.7M | ||
| Q3 24 | $12.2M | $7.4M | ||
| Q2 24 | $5.2M | $11.2M |
| Q1 26 | — | 17.1% | ||
| Q4 25 | -2.9% | 14.1% | ||
| Q3 25 | -8.7% | 40.8% | ||
| Q2 25 | -3.2% | 19.1% | ||
| Q1 25 | -2.3% | 22.2% | ||
| Q4 24 | 1.9% | 16.1% | ||
| Q3 24 | 23.7% | 10.3% | ||
| Q2 24 | 11.0% | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 8.6% | ||
| Q3 25 | 1.3% | 6.9% | ||
| Q2 25 | 3.5% | 1.9% | ||
| Q1 25 | 2.0% | 2.3% | ||
| Q4 24 | 1.6% | 5.1% | ||
| Q3 24 | 2.0% | 16.3% | ||
| Q2 24 | 2.3% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | 6.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
PUBM
Segment breakdown not available.
